High BMI and Surgical Time Are Significant Predictors of Lymphocele after Robot-Assisted Radical Prostatectomy.
RARP
lymphocele
pelvic lymph node dissection
peritoneal flap
risk factors
robot-assisted radical prostatectomy
symptomatic lymphocele
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
04 May 2023
04 May 2023
Historique:
received:
29
03
2023
revised:
28
04
2023
accepted:
02
05
2023
medline:
13
5
2023
pubmed:
13
5
2023
entrez:
13
5
2023
Statut:
epublish
Résumé
Lymphoceles (LC) occur in up to 60% after robot-assisted radical prostatectomy (RARP) and pelvic lymphadenectomy (PLND). In 2-10%, they are symptomatic and may cause complications and require treatment. Data on risk factors for the formation of lymphoceles after RARP and PNLD remain sparse in the urologic literature and are inconclusive to date. The underlying data of this secondary analysis were obtained from the prospective multi-center RCT ProLy. We performed a multivariate analysis to focus on the potential risk factors that may influence lymphocele formation. Patients with LC had a statistically significant higher BMI (27.8 vs. 26.3 kg/m
Identifiants
pubmed: 37174077
pii: cancers15092611
doi: 10.3390/cancers15092611
pmc: PMC10177373
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
Ubrig: Intuitive Surgery, Procept Biorobotics. Siemer: Intuitive Surgery. The other authors declare no conflicts of interest.
Références
Urol Int. 2021;105(5-6):453-459
pubmed: 33794533
Eur Urol Oncol. 2018 Oct;1(5):443-448
pubmed: 31158086
J Endourol. 2020 Aug;34(8):821-827
pubmed: 32303137
BJU Int. 2013 Jul;112(1):81-8
pubmed: 23351148
Int J Urol. 2013 Dec;20(12):1169-76
pubmed: 23521086
Discov Med. 2009 Aug;8(41):55-60
pubmed: 19788868
Urol Int. 2013;90(3):270-6
pubmed: 23548783
Urology. 2015 Jun;85(6):1505-9
pubmed: 26099895
Int Urol Nephrol. 2019 Apr;51(4):633-640
pubmed: 30796729
Dtsch Arztebl Int. 2020 Apr 3;117(14):243-250
pubmed: 32449896
J Urol. 2022 Aug;208(2):333-340
pubmed: 35422136
Eur Urol. 2021 May;79(5):595-604
pubmed: 33293077
Urology. 2010 Aug;76(2):398-401
pubmed: 20346487
Eur Urol. 2017 Apr;71(4):618-629
pubmed: 27568654
Scand J Urol. 2020 Aug;54(4):328-333
pubmed: 32588704
BJU Int. 2011 Oct;108(7):1185-90
pubmed: 21489117
Urol Int. 2022;106(1):28-34
pubmed: 33567440
Int J Urol. 2011 Sep;18(9):638-43
pubmed: 21689165
Eur Urol Oncol. 2021 Apr;4(2):134-149
pubmed: 33745687
Eur Urol. 2012 Sep;62(3):431-52
pubmed: 22749853
J Endourol. 2020 Feb;34(2):113-120
pubmed: 31797684
Cent European J Urol. 2021;74(3):341-347
pubmed: 34729223
Urology. 2010 Mar;75(3):630-5
pubmed: 19476977
J Robot Surg. 2019 Feb;13(1):83-89
pubmed: 29737495
BJU Int. 2011 Apr;107(7):1095-101
pubmed: 20880192
J Urol. 2007 Jun;177(6):2106-31
pubmed: 17509297
BJU Int. 2016 Jul;118(1):127-31
pubmed: 26800257
Eur Urol. 2014 Oct;66(4):635-43
pubmed: 24411992
Eur Urol. 2023 Feb;83(2):154-162
pubmed: 36041934
J Robot Surg. 2022 Nov 27;:
pubmed: 36436107
Cent European J Urol. 2020;73(4):457-465
pubmed: 33552571
Int J Urol. 2019 Jul;26(7):711-716
pubmed: 30939628
Eur Urol Oncol. 2021 Aug;4(4):532-539
pubmed: 33865797
J Laparoendosc Adv Surg Tech A. 2022 Jul;32(7):721-726
pubmed: 34677080
Urol Int. 2015;95(4):400-5
pubmed: 25871980